Complications of therapeutic apheresis, including a fatal case with pulmonary vascular occlusion.
A high incidence of anaphylactic reactions has been observed in patients undergoing therapeutic plasma exchange. In three of 22 patients who underwent multiple exchanges, urticaria, bronchospasm, and hypotension developed during a course of plasma exchange that responded to treatment with steroids, antihistamines, and epinephrine. Fatal pulmonary microvascular occlusion with platelets and granulocytes developed in an additional patient eight hours following an apheresis procedure involving albumin replacement. The mechanism for the latter complication is not known but did not appear to invoke complement activation. This unexpectedly high risk of potentially fatal complications must be considered when a course of therapeutic apheresis, particularly involving treatment of a chronic disease, is planned.
D000328:Adult; D000707:Anaphylaxis / Q000209:etiology*; D001157:Arterial Occlusive Diseases / Q000209:etiology*; D001986:Bronchial Spasm / Q000209:etiology; D002648:Child; D005260:Female; D006801:Humans; D007022:Hypotension / Q000209:etiology; D010951:Plasma Exchange / Q000009:adverse effects*; D011651:Pulmonary Artery / Q000473:pathology*; D014581:Urticaria / Q000209:etiology